Accuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference

September 24, 2007 at 2:22 PM EDT

SUNNYVALE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and CEO, Euan S. Thomson, Ph.D., is scheduled to present a corporate update at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City, on Tuesday, September 25, 2007 at 1:30 p.m. EDT.

A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at http://www.accuray.com. The webcast replay of the presentation will begin three hours after the conclusion of the live presentation and will be available until October 27, 2007.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 35,000 patients worldwide and currently more than 100 systems.

SOURCE Accuray Incorporated
09/24/2007
CONTACT: investors, Tom Rathjen, Vice President, Investor Relations,
+1-408-789-4458, trathjen@accuray.com, or media, Stephanie Tomei, Public
Relations Manager, +1-408-789-4234, stomei@accuray.com, both of Accuray
Incorporated
Web site: http://www.accuray.com